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FOREWORD 
When this research project was initiated, my advisor, Dr. 
David Maxwell, said to me, "Freda, good research answers one ques­
tion and asks ten more.·t Thus, we prepared to test our hypothesis 
regarding specific nuclear binding of estrogen in four organs of 
the laboratory rat. Based on information obtained from studies 
involving estrogen binding in the uterus, spleen, liver and large 
intestine, we hypothesized that the uterus, a well known target 
organ for estrogen, would have a high degree of specific nuclear 
binding. The large intestine, for which no evidence was found that 
implicated it as a target organ, would characteristically have a 
small amount of specific nuclear estrogen binding. The liver and 
spleen are two possible target organs. Nlore substantial research 
has been found that implicates the liver as a target organ than has 
been found implicating the spleen, so we expected to find a degree 
of specific binding in the liver somewhat less than the uterus, but 
significantly greater than the large intestine. The spleen, while 
it is a controversial organ does not seem to be as good a candidate 
for a target organ as the liver--at least not at the present--so 
we expected specific nuclear binding to be less than the liver but 
still significantly greater than the large intestine. 
This states the hypothesis of this paper and what we expect to 
see in the results. The remainder of the paper concerns itself with 
giving background information about estrogen and estrogen binding, 
with a statement of the procedure used to test the hypothesis and 
the results of that test. 
INTRODUCTION 
17s-estradiol, sometimes referred to as the "female hor­

mone", is an eighteen carbon compound having a msic steroid 

nucleus that is one in the group of hormones known as the 

estrogens. Two other naturally occurring forms of estrogen 

are estrone and estriol, but is is estradiol that is most potent 

in estrogenic biological roles and so is used in this particular 

study. 

Estrogen is characteristically thought of as one of the hormones 
that regulates the menstrual cycle and female sex behavior and which 
functions in the development and maintenance of the sex organs 
and of the secondary sex characteristics. In organs that respond 
to estrogen, its mode of action is manifested on two levelss cell ­
ular and organismal. On the cellular level, estrogen's action is 
primarily anabolic. In organs such as the uterus, a major "target" 
organ of estrogen, RNA and protein synthesis are increased as well 
as carbohydrate synthesis. There is also an increase in mitosis 
which results in increased growth. Catabolic activities such as 
carbohydrate glycolysis also show an increase in response to estrogen. 
On an organismal level in target organs, estrogen increases glycoly­
sis, respiration, H20 permeability, hyperemia, and releases hista­
mine (uterus); potentiates and stimulates thyrocalcitonin in cal­
cium bone deposition; causes development of female characteristics; 
causes growth of primary and secondary sex organs; regulates the 
menstrual cycle and sex behavior and maintains secondary sex char­
~ ·acteristics (14). 
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Estrogen Target Tissues 
Estrogen, a steroid having no apparent barrier to cellular 
permeability (11), diffuses freely across the plasma membrane 
until equilibrium is established between cytoplasm and extra­
cellular fluid. However, hormone researchers found that in some 
cells the hormone accumulated cr~ating a greater concentration of 
hormone within the cell (4). These cells were called "target" 
cells. Further study of target tissues (tissues which respond 
to a given hormone) yielded specific characteristics of target 
tissues and a mechanism by which the hormone enters the target 
cell nucleus and thereby elicits its particular response. 
Target tissues of steroid hormones are classically character­
ized by the following. 
1. 	 After in vivo exposure of the tissue to the hormone, the hormone 
appears in the tissue within minutes and is retained there long
after it has left the nontarget cells. 
2. 	 An agent is found in target cells called a "receptor", that 

binds to the hormone in the cytoplasm, and is responsible for 

its accumulation in the nucleus and moreover, its retention 

in the nucleus that is vital to hormone response. 

3. 	 The movement of the hormone into the nucleus is extremely rapid, 
preceding all other observable changes in the target cell. 
" 
4. 	 The receptor molecule must be present in the target cells of 

the hormone but absent in all other cells. 

5. 	 The receptor molecule has a high affinity for its particular 

hormone but a low affinity for other compounds of similar 

structure but different biologieal activity (18). 

Estrogen target tissues as listed by Dr. Roman J. Kutsky are. 
uterus, mammary gland, vagina, ovary (corpus luteum), secondary 
female sex organs, skin, eNS, thyroid, thymus, long bones, anterior 
pituitary and hypothalamus. As Dr. Kutsky states, conflicting 
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data exists on such topics as hormone-target tissues. There is 
evidence that suggests that some tumors (20) and other organs such 
as the liver (7) are target tissues. However, whether these tissues 
meet the full requirements for classification as an estrogen target 
organ is yet to be decided. 
Mechanism of Estrogen Entry into Nuclei 
Estrogen entry into the nucleus of target cells is accomplished 
by a "two-step" mechanism. transformation and translocation. 
The model of the two-step mechanism begins with the entry of 
the steroid, estrogen in this case, into the cytoplasm of the tar­
get cell. In the target cell cytoplasm two types of estrogen 
, 	receptors exist, nonspecific and specific. Therefore two types 
of binding exist. The first is a high affinity, low capacity 
binding characteristic of specific receptor-steroid complexes. 
, 	The second is a low affinity, high capacity binding characteristic 
of nonspecific receptor-steroid complexes. Nonspecific binding usu­
ally follows the polarity rule whereby increasing the number of 
polar sUbstituents in the steroid decreases the protein binding 
. potential. The binding is of a hydrophobic type and is somewhat 
influenced by the spatial arrangement of the steroid sUbstituents 
•but not nearly to the extent that specific binding is influenced. 
i 
IWith specific type binding, the polarity rule is not applicable and 
'the spatial arrangement of the steroid sUbstituents is of major im­
portance (11, p. 25). 
The binding of estrogen to the specific receptor causes a 
modification of the receptor. This process is known as transfor­
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mation and precedes entry of the estrogen-receptor (E-R) complex 
into the cell nucleus, a process called translocation. (8) Trans­
location of the E-R complex into the nucleus is supported by much 
evidence. Numerous reports found that injection of estradiol into 
immature rats followed by in vitro assay of the amount of cytoplas­
mic receptor indicates that there is a progressive loss of receptor 
up to four hours after the injection (maximum uptake of estrogen at 
one hour) and the amount lost is dependent on the amount of estradiol 
injected. The decrease in cytoplasmic receptors is accompanied by 
a comparable increase in the amount of bound estrogen in the nucleus 
(6). In countless similar studies examination of cytoplasmic and 
nuclear fractions of immature estrogen injected rats established 
translocation of cytoplasmic receptor as a fact. 
When the specific E-R complex enters the nucleus, it attaches 
to a nuclear component which has been called the "acceptor". The 
two candidates for the role of acceptor are DNA and a nonhistone 
protein (12). When the E-R complex binds to the acceptor, trans­
cription of mRNA is increased. The mRNA migrates to the ribosomes 
where it is translated into proteins that mediate the target tissue 
response to the hormone (18) •
• 
RATIONALE FOR THE STUDY 
The uterus has long been proven to be a major estrogen tar­
get organ and in this experiment was used as a basis for comparison 
lof specific nuclear binding of three other organs. liver, spleen, 
large intestine. The major reason for selecting these three organs 
for this study is that the liver and spleen may be regarded as 
I 
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possible estrogen target organs while the large intestine is general­
ly accepted as an estrogen nontarget organ. The establishment of 
the liver and possibly the spleen as target organs is a subject of 
much controversy_ 
Estrogens are metabolized to less active substances mainly in 
. the liver and at least in rats--in the spleen. The liver and spleen 
inactivate estrogens, and presumably the liver also converts certain 
synthetic proestrogens to more active estrogenic hormones. The 
liver secretes the estrogens to the biliary tract, where they may 
be recirculated and, in rats, but also to some extent in man, ex­
creted by way of the feces. The liver also conjugates the estrogens 
with glucuronic and sulfuric acid prior to their elimination by the 
kidneys (9). 
Conflicting evidence exists regarding the establishment of the 
liver as a target organ. There is much research being conducted 
on hormone action in the liver of various animals. Gschwendt and 
Kittstein in 1973 proposed that the liver of male chicks might be 
considered a target tissue of estrogen. However, as they stated in 
their paper, there is disagreement in the literature regarding the 
existence of a specific cytoplasmic estrogen receptor in chicken 
liver. Arias and Warren reported on a high affinity cytoplasmic 
receptor for estradiol in chicken liver (2). whereas Mester and 
Baulieu, while confirming that estradiol injection does cause a 
rapid increase in the number of estradiol binding sites in the 
nucleus found no receptor in the liver cytosol fraction under any 
physiological conditions (17). Their evidence indicated a soluble 
----·-.....EP"'--------------~~ 
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nuclear receptor. Lebeau et al (16) reported on a direct binding of 
estradiol to nuclear binding sites in vitro. However, Catherine B. 
Lazier did find a cytosol binder in the cockerel liver that is at a 
much lower concentration than the classic cytosol steroid receptors 
found in chick oviduct or rat uteri. Lazier further cited several 
repor~s that indicate that the high-affinity estradiol binding site 
concentration in rat liver cytosol is of the same order of magnitude 
(3,5,21). It is known that estradiol can also increase the concen­
tration of lipoproteins in_the rat liver (10). Powell-Jones, Davies 
and Griffiths reported their findings of a cytosol protein receptor 
in liver having a concentration of 50-100 fmol/mg protein and sug­
gested that the role of an estradiol-receptor complex in liver might 
I 
~ 	 be related to plasma protein synthesis (19). King and Mainwaring re-
I 
~ 	 ported that while liver has been used in many rat experiments as 
~ 	 non-target organs, this is probably not justified, it does respond 
to estrogen. They added that liver nuclei accept more uterine 
estradiol receptors than spleen nuclei although neither are as 
effective as uterine nuclei (11). 
t 

I Two target organs of estrogen are long bones and the thymus. 

\Estrogen is shown to affect antibody properties and while lympho- • 
cytes arise in bone marrow and some travel to the thymus to become 
T cells (where they acquire the capacity to respond to certain an­
tigens by facilitating their destruction), the spleen is a major 
lymphocyte storage organ important in both humoral and cell-mediated 
immunities (15). As stated earlier, the spleen, at least in rats is 
a site of estrogen metabolism to less active substances. This is not 
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No 
to say that any kind of estrogenic correlation can be made between 
the long bone, thymus and spleenJ however, reports do exist that show 
that the spleen is being studied as a possible target organ (11), and 
in light of this it seemed o.f interest to take a look at specific 
binding in the spleen. 
evidence for a cytosol receptor specific for estrogen in the 
was found so this made a study of the specific nuclear 
inding in this nontarget organ particularly interesting for two 
One reason was to see if the results of this study were 
urrent with the acceptance of the large intestine as a nontarget 
The second reason was that if indeed the large intestine did 
binding characteristic of a nontarget organ, it would serve 
an interesting Itnontarget'· basis of comparison for the controver­

liver and spleen in contrast to comparison with the uterus, a 

lassical estrogen target organ. 

lV'lATERIALS AND METHOD 
Animals used for this study were female Holtzman rats, 21-26 
ted, 
t 
old, which were maintained in an environmentally controlled 
boratory and fed Purina Lab Chow and water ad libitum. Four rats 
used per experiment and a total of six experiments were con-
all employing the same procedure. One hour prior to 
rifice, the rats received a 5)Jg intraperitoneal injection of 
~uHlp-led 17 fLestradiol. The rats were sacrificed by delivery of a 
blow to the head followed by rapid decapitation. Tissue samples 
four organs {uterus, spleen, liver, large intestine) of each 
were removed, freed of fat and connective tissue and immediately 
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weighed. (In the case of the uterus, the entire organ was used.) 
Separation of the two classes of bound steroid is one of the 
most practical aspects of steroid-receptor studies. With the excep­
tion of specific precipitants/adsorbants and sucrose gradient 
analysis, all of the methods used to separate high and low affinity 
binding depend either on their differences in affinity or number of 
sites. Distinction between nonspecific and specific binding sites 
cannot be made by washing because washing is a very ineffective way 
of removing nonspecific binding. A superior method is to measure 
the binding of a labelled steroid in the presence and absence of 
excess, unlabelled competitor. Labelled steroid is displaced from 
the low capacity sites by the competitor whereas the high capacity 
sites are unaffected; the difference between the two experiments is 
a measure of the high-affinity, low capacity (specific) binding. The 
ratio of labelled agonistlunlabelled antagonist in such experiments 
is governed by their relative association constants. This is a tech­
nique that can be advantageously applied to any type of tissue pre­
paration provided a method is available for separating the two classes 
of binding (ll,op. 21). 
In this study, the technique just described has been employed 
using the 3H-estradiol exchange assay of Anderson, Peck, and Clark 
(1) • 
Procedure 
Excised, weighed tissue samples were homogenized in 3 mls of 
Tris buffer solution (ph 7.4) in a Kontes all-glass homogenizer and 
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kept on ice when possible. The homogenate was then centrifuged at 
800 x g for ten minutes and the supernatant discarded. The pellet 
was resuspended in 3 mls of buffer and again centrifuged for ten min­
utes. This washing process was performed a total of three times dis­
carding the supernatant each time to remove the unbound, unlabelled 
17~estradiol. After the final washing the pellet was re-homogenized 
in 2 mls of buffer, and a .5 ml aliquot placed in each of two tubes, 
A and B. Tube A contained .2 ml of a solution of 13m)! .3H-estradiol. 
1.3M diethylstilbesterol (100 fold excess) and buffer. ~he tubes 
with .5 ml aliquots of homogenate and .2 ml of their respective sol­
utions were then placed in a 37° shaking water bath and incubated for 
one hour to allow for "exchange". In Tube A, tritiated estradiol 
exchanged with unlabelled estradiol on all the estrogen receptors. 
both specific and nonspecific. Thus a radioactivity counting of Tube 
A would result in a measure of total binding. In Tube B, two different 
exchanges took place. Unlabelled diethystilbesterol. a competitor 
for the specific binding sites, exchanged with the 17S-estradiol 
that was bound specifically. The tritiated estradiol therefore ex­
changed with the unlabelled estradiol bound to nonspecific receptors. 
A radioactivity counting of Tube B would result in a measure of the 
nonspecific binding. Specific binding would be equal to Tube A counts 
minus Tube B counts. 
RESULTS AND DISCUSSION 
In analysis of the data p <.05 confidence level was used unless 
otherwise indicated. 
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Figure 1 illustrates specific nuclear binding of estradiol in 
the rat uterus, liver, spleen and large intestine. These results 
indicate that specific nuclear binding in the liver and spleen was 
significantly lower than that of the uterus (student's t test). 
The results further indicate that specific nuclear binding in the 
large intestine is not significantly different from that of the 
uterus. This is a surprising result in light of the fact that the 
large intestine is classically not regarded as as estrogen target 
organ. 
The relationship between total, nonspecific and specific 
binding in the uterus, liver, spleen and large intestine of the 
estradiol treated rats is illustrated in Figure 2. Total binding 
of estradiol was significantly different from the uterus in the 
liver, the spleen and the large intestine. As stated earlier, 
specific nuclear binding in the spleen and liver was significantly 
different from the uterus, but specific binding in the large in­
testine was not significantly different. Importantly, nonspecific 
binding which was expected to show no significant difference in any 
of the organs did show a significant difference in the liver and 
spleen but not in the large intestine. 
Figure 3 illustrates the ratio of specifically bound estradiol 
to the total amount of estradiol bound in the uterus, liver, spleen 
and large intestine. The liver showed significant difference with 
respect to the uterus. However, the spleen and large intestine did not 
show a significant difference. 
It must be said that the results of this study are indeed 
11 
surp~ising. Much of that surprise results from the high amount of 
specific nuclear binding found in the large intestine. Inevitably 
one must ask, "Why would the large intestine exhibit estrogen target 
organ characteristics? What would be the t=I,dvantage in having estro­
gen accumulate in the nuclei of the cells of the large intestine"" 
This paper cannot answer those questions; it can only raise 
those and more. At this point, any attempt to explain what happened 
in this experiment would be pure speculation and faced with these 
astonishing results regarding the liver and large intestine, even 
speculation is not easy. 
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Figure 1. 	Specific nuclear binding of estradiol in the rat 
uterus, liver. spleen and large intestine. Each 
value is the mean (+ S.E.) based on six experiments. 
Values are expressed as specific counts per minute 
per milligram of tissue, 
* = significantly different from uterus at p< .05. 
60 
50 
140 
30 
o 
o 
o 
o 
o 
o 
o 
o 
13 
• 
..,..-
T
-l- i 
... 
~-
* 
-l 
-I'" 
* 
..... 
_T
_L. ..... 
1 
T* 
~ 
N 
Spleen 
..... 
* 
.. * I 
.L 
L 
S N T N T S T S N T 
Uterus Liver L. Intestine 
Figure 2\ 	 Total, specific and nonspecific binding of estradiol 
in the uterus, liver, spleen and large intestine of 
estradiol-treated rats. Each value is the mean- (± 
S.E.) based on six experiments. Values"are .xpressed 
as counts'per minute per milligram of tissue. 
* = significantly different from uterus a~ p <.05. 
S = specific; N =nonspecific. T = total 
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Figure J. Ratio of specific nuclear counts to total 
number of counts in the uterus, liver, spleen 
and large intestine of rats treated with estradiol. 
Each value is the mean (± S.E.) based on six ex­
periments. Values are expressed as counts per
minute per milligram of tissue. 
* = significantly different from uterus at p <.05. 
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CONCLUSIONS 
1. 	 The large intestine exhibits no significant difference to the 
uterus in the specific nuclear binding of 178-estradiol at the 
p <.05 level. Therefore, the large intestine may be regarded 
as an estrogen target organ. 
2. 	 The liver shows significantly less specific nuclear binding of 
17S-estradiol. 
3. 	 The spleen shows significantly less specific nuclear binding of 
17S - estradiol. 
4. 	 Further research is needed to confirm the surprising findings 
of this study. That research might be~in with a repeat of this 
study using, in addition to the estrogen injected rat, an un­
injected control rat and making a determination of the specific 
nuclear binding for the purpose of basal comparison. Also a 
time sequence study on estradiol treated rats could be conducted. 
Other suggested projects would be those that attempt to answer 
such questions as, "Does the increase in nuclear binding in the 
large intestine of the rat correlate to an increase in metabolic 
rate, and if so, how is this change in metabolic rate manifested? 
What is the mechanism by which estrogen enters the cell nucleus 
of the liver, spleen and large intestine? Is it the two-step 
method of translocation and transformation, some other method 
or a combination of methods?" Lastly, a question that is very 
thought provoking and is intimately related to all that we have 
talked about in this paper, While virtually all tissues that 
contain estrogen receptors are estrogen responsive, the very 
important question of whether all responsive cells contain re­
ceptors is a question that still remains to be answered. 
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